Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
G. Özgül (Istanbul, Turkey), A. Koç (Agri, Turkey), D. Turan (Istanbul, Turkey), S. Küçük (Istanbul, Turkey), S. Özsoy (Istanbul, Turkey), K. Baydili (Istanbul, Turkey), E. Güler (Istanbul, Turkey), M. Özgül (Istanbul, Turkey), Z. Egri Kansu (Istanbul, Turkey), E. Seyhan (Istanbul, Turkey). DR-70, A promising biomarker for the detection of lung cancer>. 2178

Member's Comments

No comment yet.

Related content which might interest you: Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003 Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 Validation of a gene-based lung cancer risk test (Respiragene) for high risk smokers: A targeted approach to early detection of lung cancer Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 New techniques for early detection of lung cancer Source: Eur Respir J 2003; 21: 57S-66S Year: 2003 Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Screening Source: Eur Respir J 2003; 21: 3S-15S Year: 2003 COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Can high levels of serum tumor markers be useful in predicting the histologic type of lung cancer? Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004 Identification of genes with diagnostic and prognostic value in lung cancer. Source: International Congress 2019 – Biology of lung cancer Year: 2019 Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 Early detection of lung cancer Source: Annual Congress 2013 –Biological signatures in thoracic oncology Year: 2013 Issues other than tissue: non-invasive biomarkers of early stage lung cancer Source: Virtual Congress 2020 – Will the pulmonologist still play a role in the management of screen-detected pulmonary nodules? Year: 2020 A novel biologic classification of non-small cell lung cancer Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer Source: Eur Respir J 2010; 36: 885-892 Year: 2010 The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 The detection of quantitative serum p53 protein in lung cancer and its clinical value Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009